Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
Sun Pharmaceutical Industries Ltd. signage is displayed outside the company's corporate office in Mumbai. © 2014 Bloomberg Finance LP Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi —has agreed to…
Watch Bernstein's Liang on China's Edge in Pharma Sector
Bernstein's Liang on China's Edge in Pharma Sector China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing. Rebecca Liang, a senior analyst…
Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase
Sun Pharmaceutical Industries Ltd. has lined up a short-term loan to help finance its $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the transaction. At least three banks —…
Sun Pharma's Dilip Shanghvi on Organon Acquisition: Debt, China Market & Biosimilars
Sun Pharmaceutical Industries' executive chairman Dilip Shanghvi shares his mixed feelings of happiness and anxiety regarding the company's $11.75 billion acquisition of US-based Organon & Co, a strategic move set to expand Sun Pharma's global…
Indian Stock Markets Rebound: Sensex Jumps 639 Points, Nifty Up on Global Cues, Sun Pharma & RIL Rally
Indian benchmark stock indices Sensex and Nifty staged a significant rebound, snapping a three-day losing streak, fuelled by strong performances from Reliance Industries and Sun Pharma, coupled with positive global market trends and easing…
Indian Stock Markets Rebound: Sun Pharma Acquisition, Global Cues Drive Gains
Indian benchmark indices Sensex and Nifty staged a significant rebound in early trade, buoyed by Sun Pharma's major acquisition of US-based Organon & Co and positive global market trends, ending a three-day period of decline. Benchmark indices…
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women's health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years. Sun Pharma will pay $14 per Organon share in cash, giving the…
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Sun Pharmaceutical Industries Ltd is set to acquire US-based Organon & Co for a staggering $11.75 billion, a strategic move poised to significantly expand its global footprint and elevate its standing among the world's top pharmaceutical companies.
Sun Pharma Founder Says 'Debt-Averse, Not Risk-Averse' After $12 billion Organon Buy
Welcome to India Edition, Bloomberg's daily dive into what's moving the worlds of business, markets and politics in this dynamic, fast-paced economy. I'm Menaka Doshi. If you didn't receive this directly in your inbox, you can subscribe here, and…
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share. The acquisition will…
Sun Pharma To Purchase US-listed Organon In A Nearly $11.8 billion Deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals. The acquisition would help Sun Pharma further expand its women's…
Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an all‑cash transaction with an enterprise valuation of…
Focus on these 4 pharma stocks: Sun Pharma, Zydus, Alembi, Rubicon on Monday
Sun Pharmaceutical Industries and US-based Organon & Co have entered into an agreement under which Sun will acquire all outstanding shares of Organon for $14 per share in an all-cash transaction with an enterprise valuation of $11.75 billion…
Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant
5 min read Mumbai Make us preferred source on Google In a significant overseas acquisition, Sun Pharmaceutical Industries, India's largest pharmaceutical company, and US-based Organon & Co have announced that they have entered into a definitive…
Stock markets bounce back after three-day decline
Benchmark stock indices Sensex and Nifty rebounded nearly 1 per cent on Monday, snapping the three-day falling streak following a rally in Reliance Industries and Sun Pharma and positive global trends. The 30-share BSE Sensex jumped 639.42 points…
Receive a Daily briefing on Pharma Industry News
Get Started